{
    "2020-02-13": [
        [
            {
                "time": "",
                "original_text": "药明康德升逾1% 创上市新高",
                "features": {
                    "keywords": [
                        "药明康德",
                        "上市新高"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "国泰君安证券：CRO/CDMO已在复工 疫情对全年高景气影响有限",
                "features": {
                    "keywords": [
                        "国泰君安",
                        "CRO",
                        "CDMO",
                        "复工",
                        "疫情",
                        "高景气"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}